Cabenuva approval date?

When was Cabenuva approved?

Cabenuva (cabotegravir/rilpivirine) received FDA approval on January 21, 2021. [1]

What was the first approval for?

That approval was for Cabenuva injection as a complete, long-acting regimen for certain adults with HIV who are virologically suppressed on a stable antiretroviral regimen. [1]

Sources

1. [DrugPatentWatch – Cabenuva (cabotegravir/rilpivirine) approval date](https://www.drugpatentwatch.com/patent/ cabenuva-cabotegravir-rilpivirine/)